Pharma's Almanac | Roundtable

51 Articles Available

1 3

Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

PAO-12-21-RT-01

Therapeutic Progress

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

PAO-12-21-RT-02

Social Media Marketing

Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?

Evolving Technologies

Q: What do you think most differentiates the U.S. pharma/biopharma industry or the market?

Evolving Technologies

Q: How have evolving technologies like artificial intelligence (AI) and machine learning (ML) changed how you conduct research, manufacturing, or business?

PAO-06-21-RT-1

Social Media Marketing

Q: How is your organization using social media to extend your marketing efforts?

PAO-06-21-RT-2

Business Development

Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?

PAO-03-21-NI-02

COVID-19 Impacts

Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

PAO-03-21-NI-01

COVID-19 Impacts

Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?

PAP-Q4-20-NI-006

Roundtable

Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?

PAP-Q4-20-NI-007

Post COVID-19 Supply Chain

Q: How are you rethinking your supply chain and operational fitness in light of the COVID-19 pandemic?

PAP-Q3-20-NI-007

Roundtable

Q: What steps is your company taking to address drug pricing issues?

PAP-Q3-20-NI-008

COVID-19

Q: What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned?

PAP-Q2-20-RT-001

Roundtable

Q: What two or three drug molecules do you identify as having had the greatest impact on society? What about on the pharmaceutical industry?

PAP-Q2-20-RT-002

M&A

Q: How would you characterize the current landscape of M&A activity in the pharmaceutical/biopharmaceutical industry?

PAP-Q1-20-NI-008

Technology

Q: What technology do you foresee leading the industry over the coming decade, both in terms of real approvals and general impact?

PAP-Q1-20-NI-009

Technology

Q: What developing technologies do you believe will have the greatest impact on the biopharma industry in 2020 and beyond?

PAP-Q4-19-NI-006

Technology

Q: What breakthrough technologies have had a transformative effect on your business this year?

PAP-Q4-19-NI-005

Manufacturing Technology

Q: How does your company manage to provide local services/support while still efficiently managing global compliance?

PAP-Q2-19-NI-006

Novel Therapies

Q: What do you identify as the greatest advances that have been achieved in recent years with respect to harmonization of pharmaceutical regulations?

PAP-Q2-19-NI-007

Manufacturing Technology

Q: What advances in manufacturing technology are most enabling the scale-up and commercialization of next-generation therapies?

PAP-Q2-2019-NI-006

Novel Therapies

Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?

PAP-Q2-2019-NI-007

Ethical Business Practices

Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?

PAP-Q1-2019-NI-001

Artificial Intelligence

Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?

PAP-Q1-2019-NI-002

1 3

Roundtable

51 Articles Available

Can't find what you're looking for? Try our advanced search.

Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Therapeutic Progress

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

Social Media Marketing

Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?

Evolving Technologies

Q: What do you think most differentiates the U.S. pharma/biopharma industry or the market?

Evolving Technologies

Q: How have evolving technologies like artificial intelligence (AI) and machine learning (ML) changed how you conduct research, manufacturing, or business?

Social Media Marketing

Q: How is your organization using social media to extend your marketing efforts?

Business Development

Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?

COVID-19 Impacts

Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

COVID-19 Impacts

Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?

Roundtable

Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?

Post COVID-19 Supply Chain

Q: How are you rethinking your supply chain and operational fitness in light of the COVID-19 pandemic?

Roundtable

Q: What steps is your company taking to address drug pricing issues?

COVID-19

Q: What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned?

Roundtable

Q: What two or three drug molecules do you identify as having had the greatest impact on society? What about on the pharmaceutical industry?

M&A

Q: How would you characterize the current landscape of M&A activity in the pharmaceutical/biopharmaceutical industry?

Technology

Q: What technology do you foresee leading the industry over the coming decade, both in terms of real approvals and general impact?

Technology

Q: What developing technologies do you believe will have the greatest impact on the biopharma industry in 2020 and beyond?

Technology

Q: What breakthrough technologies have had a transformative effect on your business this year?

Manufacturing Technology

Q: How does your company manage to provide local services/support while still efficiently managing global compliance?

Novel Therapies

Q: What do you identify as the greatest advances that have been achieved in recent years with respect to harmonization of pharmaceutical regulations?

Manufacturing Technology

Q: What advances in manufacturing technology are most enabling the scale-up and commercialization of next-generation therapies?

Novel Therapies

Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?

Ethical Business Practices

Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?

Artificial Intelligence

Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?